TRIA
ABBV icon

Trail Ridge Investment Advisors’s AbbVie ABBV Stock Holding History

Trail Ridge Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$525K Sell
2,085
-63
-3% -$13.6K 0.22% 67
2026
Q1 		$467K Buy
2,148
+33
+2% +$7.32K 0.2% 75
2025
Q4 		$483K Buy
2,115
+25
+1% +$5.7K 0.21% 73
2025
Q3 		$484K Buy
2,090
+668
+47% +$136K 0.22% 74
2025
Q2 		$269K Sell
1,422
-100
-7% -$18.6K 0.13% 90
2025
Q1 		$319K Sell
1,522
-386
-20% -$75K 0.16% 83
2024
Q4 		$339K Buy
1,908
+30
+2% +$5.52K 0.16% 88
2024
Q3 		$353K Buy
1,878
+13
+0.7% +$2.43K 0.17% 87
2024
Q2 		$320K Buy
1,865
+466
+33% +$77.2K 0.17% 87
2024
Q1 		$255K Sell
1,399
-287
-17% -$49.5K 0.14% 92
2023
Q4 		$261K Sell
1,686
-70
-4% -$10.2K 0.16% 95
2023
Q3 		$262K Buy
+1,756
New +$258K 0.18% 90
2023
Q2 		– Sell
-1,637
Closed -$261K – 114
2023
Q1 		$261K Buy
+1,637
New +$250K 0.17% 102

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Trail Ridge Investment Advisors's ABBV Position: Q2 2026 in Review

Trail Ridge Investment Advisors reduced its AbbVie (ABBV) stake by 2.9% in Q2 2026, selling an estimated $13.6K and leaving 2,085 shares worth $525K. The position accounts for 0.22% of the portfolio, ranked #67.

Trail Ridge Investment Advisors first reported a position in ABBV in Q1 2023 and has held it in 13 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Trail Ridge Investment Advisors held 2,085 shares of AbbVie worth $525K as of Q2 2026.
  • Trail Ridge Investment Advisors sold 63 AbbVie shares in Q2 2026, an estimated $13.6K.
  • AbbVie made up 0.22% of Trail Ridge Investment Advisors's portfolio in Q2 2026, its #67 holding.
  • Trail Ridge Investment Advisors first reported a position in AbbVie in Q1 2023 and has held it in 13 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Trail Ridge Investment Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.